Erik Harris
Impact in
-
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- S100 Proteins and Annexins
- Cancer therapeutics and mechanisms
- Cancer-related gene regulation
- Wnt/β-catenin signaling in development and cancer
- DNA Repair Mechanisms
Papers in
-
- Protein Degradation and Inhibitors 3
- Wnt/β-catenin signaling in development and cancer 2
- S100 Proteins and Annexins 2
- DNA Repair Mechanisms 2
- Cancer-related gene regulation 2
- Advanced biosensing and bioanalysis techniques 1
- Signaling Pathways in Disease 1
- Oncology 4
- Co-authors
- Anne Monks (9 shared papers)Edward A. Sausville (2 shared papers)Curtis Hose (3 shared papers)John Connelly (5 shared papers)Robert H. Shoemaker (3 shared papers)Susan D. Mertins (1 shared paper)David Allard (1 shared paper)Janice Smith (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Cancers (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Erik Harris
12 papers receiving 614 citations
Peers
Comparison fields: 5 of 69
- Oncology 215
- Molecular Biology 425
- Cancer Research 93
- Immunology 71
- Toxicology 9
Countries citing papers authored by Erik Harris
This map shows the geographic impact of Erik Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Harris more than expected).
Fields of papers citing papers by Erik Harris
This network shows the impact of papers produced by Erik Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Harris. The network helps show where Erik Harris may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 187 | |
| 2 | 2016 | 106 | |
| 3 | 2005 | 78 | |
| 4 | 2000 | 67 | |
| 5 | 2015 | 55 | |
| 6 | 2003 | 47 | |
| 7 | 2017 | 25 | |
| 8 | 2019 | 22 | |
| 9 | 2006 | 19 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 8 | |
| 12 | A sterol mesylate activator of CEBPα signaling induces monocytic differentiation in human leukemia cells in vitro and in vivo | 2006 | 3 |
About Erik Harris
Erik Harris is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Infectious Diseases and Organic Chemistry, having authored 12 papers that have together received 626 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), S100 Proteins and Annexins (2 papers), DNA Repair Mechanisms (2 papers), Cancer-related gene regulation (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Signaling Pathways in Disease (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Oncology (215 citations), Molecular Biology (425 citations), Cancer Research (93 citations), Immunology (71 citations) and Toxicology (9 citations). Erik Harris has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Anne Monks, Edward A. Sausville, Curtis Hose, John Connelly, Robert H. Shoemaker, Susan D. Mertins, David Allard, Janice Smith, Ulrike Stein and Franziska Arlt. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Cancers, JNCI Journal of the National Cancer Institute and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.